As vice president of U.S. sales at Takeda Oncology, Joe Regan oversees the distribution of revolutionary drugs for conditions currently devoid of treatment. One such example is the NINLARO drug for the treatment of multiple myeloma, a blood cancer currently without any cure. Takeda acquired the group Ariad in 2015, and will soon initiate its launch of another new drug, Alunbrig, for the treatment of non-small cell lung cancer.

Born to James Regan and his wife Marion (née Monaghan) in Charles City, Iowa, Joe earned his degree in finance from Indiana University while also working full-time as a laborer in an industrial pump assembly factory for seven years.

Joe is a fourth-generation Irish American, with the ancestors of both his parents originating in County Cork. “To me, being Irish means having and sharing a strong sense of family, culture and tradition,” he says, and shares these values with his own family, consisting of his wife, Vicki, and children, Patrick and Christina. Joe is based in Massachusetts.